Table 3.
Correlation between biomarker levels in the total population, healthy individuals, and patients with EOA or LOA
Biomarkers | Total population | Healthy | EOA | LOA | ||||
---|---|---|---|---|---|---|---|---|
r | p | r | p | r | p | r | p | |
COMP vs HA | 0.121 | > 0.05 | 0.072 | > 0.05 | 0.017 | > 0.05 | 0.177 | < 0.05 |
COMP vs PIICP | −0.184 | < 0.01 | 0.086 | > 0.05 | 0.448 | < 0.01 | −0.307 | < 0.0001 |
PIICP vs HA | −0.030 | > 0.05 | 0.050 | > 0.05 | −0.117 | > 0.05 | 0.123 | > 0.05 |
EOA Early Osteoarthritis, LOA Late Osteoarthritis. Correlation analysis between biomarker levels was performed using Spearman’s rank correlation coefficient (r). All reported p-values are two-tailed. p-values < 0.05 were considered statistically significant and indicated in bold